Board of Directors
Steve is the former CIO of Vertex Pharmaceuticals, Manger at Abbott Labs & Park-Davis Pharmaceutical Research. He has 25 years experience building health and life sciences software with simple user interfaces over complex solutions. He is the parent of an asthmatic child, as well as a medicinal chemist who worked the asthma drug Zyflo®. Steve is also CEO of Quvium.
Chris is a Strategic Hardware Advisor and the CEO and Founder of nTETE Group, which consults on global strategy, innovation management, funding, supply chain operations, IP licensing and business development, with an emphasis on the mobile market. He is a partner in Thingovation, a consulting company, and serves on various business and key technology association boards. He was recently the CEO of a UK-based Wireless Security IP company and is a Partner in MoveableCode, Inc., a SoLoMo venture in the gaming/play arena. Before that he was the Head of Technology Incubation and Head of Sourcing (PBUC) at Sony Ericsson. Chris is a Companion and Chartered Manager of the Chartered Management Institute (UK).
Mark is a senior pharmaceutical executive focused on strategic thinking, drug hunting, disruptive innovation, team-building, and mentoring across the entire pharma/biotech enterprise - discovery, development, manufacturing, and commercial. Mark is co-inventor of four marketed drugs and numerous additional clinical candidates; has >50 issued/pending patents, >85 publications and >170 invited scientific lectures; a current or past member of >12 journal editorial boards; and is former Chair of Vertex Pharmaceuticals Inc’s Scientific Advisory Board. Mark is SVP of Long-term Strategy, Schrödinger, LLC; Senior Lecturer, MIT; Professor of Practice, Northeastern; and an active consultant, advisor, or board member with ~20 entities.
David has more than 25 years' experience in building high performing organisations. Most recently he was the head of corporate development for Tufts Plan, a £5B health insurance company, responsible for all aspects of the acquisition, venture investment, and portfolio management process. Prior to that, he was in management consulting assisting senior leadership with organic and inorganic growth strategy and execution. David has been a business advisor to the UK government since 2004. He holds a BS in Marketing and International Business from the D'Amore School of Business at Northeastern University.
Bob is a talented operational executive with strong background in finance. Successful business partner to CEO, board of directors, and investors and skilled in P&L management, restructuring, strategic planning, venture financing and M&A. He is a hands-on entrepreneurial problem-solver who thrives in dynamic environments and leads with emotional intelligence and high integrity.
Gabe is an executive, experienced in a diverse range of businesses, who is currently engaged in venture capital consulting, which entails reviewing marketing plans as well as other due diligence documents presented by business leaders, enterprise owners and entrepreneurs seeking capital. As an entrepreneur, Galt designed a wide range of consumer products from electronics to sports equipment. He also helped many small businesses around the country develop and implement new marketing plans. Most recently, Galt founded RGC Capital to be the financing liaison to the Stanchion Assurance Corporation, Inc. (Stanchion) structure for non-traditional venture capital (NTVC).